Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-18

FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Torrent Pharmaceuticals Limited, granting the requested modification under the existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)